RGM.20.007 – Large-scale neo-cartilage engineering, a regenerative treatment for osteoarthritis
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
Osteoarthritis (OA) is a degenerative joint disease affecting over 1.3 million people in the Netherlands, causing an estimated annual economic […]
View the initiative
PM.20.052 – Personalized medicine in osteoarthritis
Route: Personalised medicine: the individual at the centre
cluster question: 101 Can we model the human body and use smart technologies for health, nutritional, and toxicity research, drastically reducing the use of laboratory animals at the same time?
Osteoarthritis is one of the most common chronic diseases characterized by gradual joint deterioration. The disease presentation is highly variable […]
View the initiative
PM.20.014 – Healthy loading to combat osteoarthritis: Leveraging molecular variations in load bearing capacity for individualized movement advice
Route: Personalised medicine: the individual at the centre
cluster question: 102 How can we develop new drugs and treatment methods that will keep us as healthy and vigorous as possible?
Osteoarthritis. a painful and disabling joint disease, affects over 1.2 million people in the Netherlands. There is no cure for […]
View the initiative